Pfizer To Acquire Blood Disorder Drugmaker Global Blood Therapeutics For $5.4B

Pfizer Inc. (NYSE:PFE) has reached an agreement to acquire Global Blood Therapeutics Inc (NASDAQ:GBT) in a deal with $5.4 billion.

Related Keywords

Walter Schloss ,Letter To Co ,Global Blood Therapeutics Inc ,Pfizer ,Biohaven Pharmaceutical Holding ,Pfizer Inc ,Cantor Fitzgerald ,Arena Pharmaceuticals ,Rv Capital Co ,Dear Co ,Global Blood Therapeutics ,Wall Street Journal ,Full Walter Schloss Series ,Co Investor Letter ,Dear Co Investors ,Wall Street ,